All rights reserved. This material may be freely reproduced for educational and not-for-profit purposes. No reproduction by or for commercial organisations, or for commercial purposes, is allowed without the express written permission of NICE.
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Peritoneal Dialysis: Peritoneal Dialysis in the Treatment of Stage 5 Chronic Kidney Disease. London: National Institute for Health and Clinical Excellence (NICE); 2011 Jul. (NICE Clinical Guidelines, No. 125.)
Peritoneal Dialysis: Peritoneal Dialysis in the Treatment of Stage 5 Chronic Kidney Disease.
Show details9.1. The Guideline Development Group
Lindsey Barker
Consultant Nephrologist and Medical Director, Royal Berkshire Hospital Foundation Trust, Reading
Hilary Bekker
Senior Lecturer in Behavioural Sciences, Leeds Institute of Health Sciences, School of Medicine, University of Leeds,
David Bennett-Jones
Consultant, Renal Medicine, University Hospital Coventry and Warwickshire
Roy Connell
Clinical Nurse Specialist, Nottingham University Hospital
Robert Dunn
Patient and carer member, National Kidney Federation
Helen Hurst
Advanced Nurse Practitioner, Manchester Royal Infirmary
Lesley Lappin
Clinical Nurse Specialist/Community Dialysis Manager, Salford Royal Infirmary, Manchester
Damien Longson – Chair
Consultant Liaison Psychiatrist, Manchester Mental Health and Social Care Trust
Sue Perry
Deputy Head of Dietetic Services, Hull and East Yorkshire Hospitals
Lesley Rees
Consultant Paediatric Nephrologist, Great Ormond St Hospital for Children NHS Trust, London
Amanda Venters
Patient and carer member
9.2. The short clinical guidelines technical team
A short clinical guidelines technical team was responsible for this guideline throughout its development. It prepared information for the Guideline Development Group, drafted the guideline and responded to consultation comments. The following NICE employees made up the technical team for this guideline.
Kathryn Chamberlain
Project Manager
Mendwas Dzingina
Technical Analyst (Health Economics) (from February 2011)
Sarah Glover
Information Specialist
Prashanth Kandaswamy
Technical Adviser (Health Economics)
Beth Shaw
Technical Adviser
Sheryl Warttig
Technical Analyst (from February 2011)
9.3. The short clinical guidelines team
Mark Baker
Consultant Clinical Adviser
Nicole Elliott
Associate Director
Michael Heath
Programme Manager
9.4. Centre for clinical practice
Emma Banks
Guidelines Coordinator
Stefanie Reken
Technical Analyst (Health Economics)
Judith Richardson
Associate Director
Rachel Ryle
Guidelines Commissioning Manager
Judith Thornton
Technical Adviser
Rachael Paterson, Korin Knight-Mossop, Susan Burlace
Editors
9.5. The Guideline Review Panel
The Guideline Review Panel is an independent panel that oversees the development of the guideline and takes responsibility for monitoring adherence to NICE guideline development processes. In particular, the panel ensures that stakeholder comments have been adequately considered and responded to. The panel includes members from the following perspectives: primary care, secondary care, lay, public health and industry.
Dr John Hyslop (Chair)
Consultant Radiologist, Royal Cornwall Hospital NHS Trust
Mrs Sarah Fishburn
Patient and carer member
Mr Kieran Murphy
Health Economics and Reimbursement Manager, Johnson & Johnson Medical Devices & Diagnostics (UK)
Dr Ash Paul
Deputy Medical Director, Health Commission Wales
Professor Liam Smeeth
Professor of Clinical Epidemiology, London School of Hygiene and Tropical Medicine
9.6. Declarations of interest
A full list of all declarations of interest made by this Guideline Development Group is available on the NICE website (www.nice.org.uk).
9.7. Authorship and citation
Authorship of this document is attributed to the NICE Short Clinical Guidelines Technical Team and members of the Guideline Development Group under group authorship.
The guideline should be cited as:
National Institute for Health and Clinical Excellence (2011) Kidney disease: peritoneal dialysis in the treatment of stage 5 chronic kidney disease. London: National Institute for Health and Clinical Excellence. Available from: www.nice.org.uk/guidance/CG125
- Contributors - Peritoneal DialysisContributors - Peritoneal Dialysis
Your browsing activity is empty.
Activity recording is turned off.
See more...